The Multi-Faceted Effect of Curcumin in Glioblastoma from Rescuing Cell Clearance to Autophagy-Independent Effects

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2020 Oct 23

PMID 33092261

Citations 28

Authors

Larisa Ryskalin

Francesca Biagioni

Carla L Busceti

Gloria Lazzeri

Alessandro Frati

Francesco Fornai

Affiliations

Soon will be listed here.

Abstract

The present review focuses on the multi-faceted effects of curcumin on the neurobiology glioblastoma multiforme (GBM), with a special emphasis on autophagy (ATG)-dependent molecular pathways activated by such a natural polyphenol. This is consistent with the effects of curcumin in a variety of experimental models of neurodegeneration, where the molecular events partially overlap with GBM. In fact, curcumin broadly affects various signaling pathways, which are similarly affected in cell degeneration and cell differentiation. The antitumoral effects of curcumin include growth inhibition, cell cycle arrest, anti-migration and anti-invasion, as well as chemo- and radio-sensitizing activity. Remarkably, most of these effects rely on mammalian target of rapamycin (mTOR)-dependent ATG induction. In addition, curcumin targets undifferentiated and highly tumorigenic GBM cancer stem cells (GSCs). When rescuing ATG with curcumin, the tumorigenic feature of GSCs is suppressed, thus counteracting GBM establishment and growth. It is noteworthy that targeting GSCs may also help overcome therapeutic resistance and reduce tumor relapse, which may lead to a significant improvement of GBM prognosis. The present review focuses on the multi-faceted effects of curcumin on GBM neurobiology, which represents an extension to its neuroprotective efficacy.

Citing Articles

Advances in nano-delivery of phytochemicals for glioblastoma treatment.

Ambele M, Maebele L, Mulaudzi T, Kungoane T, Damane B Discov Nano. 2024; 19(1):216.

PMID: 39718730 PMC: 11668727. DOI: 10.1186/s11671-024-04172-9.

The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway.

Zoi V, Kyritsis A, Galani V, Lazari D, Sioka C, Voulgaris S Cancers (Basel). 2024; 16(8).

PMID: 38672636 PMC: 11048628. DOI: 10.3390/cancers16081554.

Action of Curcumin on Glioblastoma Growth: A Systematic Review with Meta-Analysis of Animal Model Studies.

Luis A, Amaral L, Domingues F, Pereira L, Cascalheira J Biomedicines. 2024; 12(2).

PMID: 38397870 PMC: 10886523. DOI: 10.3390/biomedicines12020268.

Toxicity Evaluation and Controlled-Release of Curcumin-Loaded Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles: In Vitro and In Vivo Models.

Luss A, Bagrov D, Yagolovich A, Kukovyakina E, Khan I, Pokrovsky V Pharmaceutics. 2024; 16(1).

PMID: 38276486 PMC: 10818735. DOI: 10.3390/pharmaceutics16010008.

Autophagy Modulation and Its Implications on Glioblastoma Treatment.

Chen J, Rodriguez A, Morales M, Fang X Curr Issues Mol Biol. 2023; 45(11):8687-8703.

PMID: 37998723 PMC: 10670099. DOI: 10.3390/cimb45110546.

References

Beevers C, Chen L, Liu L, Luo Y, Webster N, Huang S . Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Cancer Res. 2009; 69(3):1000-8. PMC: 4307947. DOI: 10.1158/0008-5472.CAN-08-2367. View

Sansalone L, Veliz E, Myrthil N, Stathias V, Walters W, Torrens I . Novel Bis-Chalcone Promotes Endoplasmic Reticulum Stress and Glioblastoma Neurosphere Cell Death. Cancers (Basel). 2019; 11(3). PMC: 6468769. DOI: 10.3390/cancers11030357. View

Oshima M, Seki T, Kurauchi Y, Hisatsune A, Katsuki H . Reciprocal Regulation of Chaperone-Mediated Autophagy/Microautophagy and Exosome Release. Biol Pharm Bull. 2019; 42(8):1394-1401. DOI: 10.1248/bpb.b19-00316. View

Zhuang W, Long L, Zheng B, Ji W, Yang N, Zhang Q . Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy. Cancer Sci. 2011; 103(4):684-90. PMC: 7659256. DOI: 10.1111/j.1349-7006.2011.02198.x. View

Lim K, Bisht S, Bar E, Maitra A, Eberhart C . A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther. 2011; 11(5):464-73. PMC: 3087900. DOI: 10.4161/cbt.11.5.14410. View

Su C, Wang M, Chiu T . The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma. Int J Mol Med. 2010; 26(2):217-24. DOI: 10.3892/ijmm_00000455. View

Senft C, Polacin M, Priester M, Seifert V, Kogel D, Weissenberger J . The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer. 2010; 10:491. PMC: 2949804. DOI: 10.1186/1471-2407-10-491. View

Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

Shin H, Lee S, Jung H . A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca /calmodulin-dependent protein kinase II. J Cell Biochem. 2018; 120(4):6741-6752. DOI: 10.1002/jcb.27972. View

10.

Gupta S, Prasad S, Kim J, Patchva S, Webb L, Priyadarsini I . Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep. 2011; 28(12):1937-55. PMC: 3604998. DOI: 10.1039/c1np00051a. View

11.

Lin C, Yu K, Jheng C, Chung R, Lee C . Curcumin reduces amyloid fibrillation of prion protein and decreases reactive oxidative stress. Pathogens. 2014; 2(3):506-19. PMC: 4235698. DOI: 10.3390/pathogens2030506. View

12.

Maiti P, Scott J, Sengupta D, Al-Gharaibeh A, Dunbar G . Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells. Int J Mol Sci. 2019; 20(2). PMC: 6359162. DOI: 10.3390/ijms20020399. View

13.

Aggarwal B, Shishodia S, Takada Y, Banerjee S, Newman R, Bueso-Ramos C . Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res. 2005; 11(20):7490-8. DOI: 10.1158/1078-0432.CCR-05-1192. View

14.

Drion C, van Scheppingen J, Arena A, Geijtenbeek K, Kooijman L, van Vliet E . Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy. J Neuroinflammation. 2018; 15(1):212. PMC: 6056921. DOI: 10.1186/s12974-018-1247-9. View

15.

de Vrij J, Maas S, Kwappenberg K, Schnoor R, Kleijn A, Dekker L . Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells. Int J Cancer. 2015; 137(7):1630-42. DOI: 10.1002/ijc.29521. View

16.

Shi L, Fei X, Wang Z . Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells. Tumour Biol. 2015; 36(9):7107-19. DOI: 10.1007/s13277-015-3427-x. View

17.

Mao H, LeBrun D, Yang J, Zhu V, Li M . Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. Cancer Invest. 2012; 30(1):48-56. PMC: 3799884. DOI: 10.3109/07357907.2011.630050. View

18.

Poehler A, Xiang W, Spitzer P, May V, Meixner H, Rockenstein E . Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment. Autophagy. 2014; 10(12):2171-92. PMC: 4502760. DOI: 10.4161/auto.36436. View

19.

Woo M, Jung S, Kim S, Hyun J, Ko K, Kim W . Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem Biophys Res Commun. 2005; 335(4):1017-25. DOI: 10.1016/j.bbrc.2005.07.174. View

20.

Qazi M, Vora P, Venugopal C, Sidhu S, Moffat J, Swanton C . Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma. Ann Oncol. 2017; 28(7):1448-1456. DOI: 10.1093/annonc/mdx169. View